Skip to Content
U.S. National Institutes of Health
Cancer Diagnosis Program Cancer Imaging Program Cancer Therapy Evaluation Program Developmental Therapeutics Program Radiation Research Program Translational Research Program Biometric Research Branch Office of Cancer Complementary and Alternative Medicine
Last Updated: 04/25/2012

CURRENT FUNDING OPPORTUNITIES

Image-Guided Drug Delivery (R01)

Program Announcement

PA-09-253: http://grants.nih.gov/grants/guide/pa-files/PA-09-253.html
(Expiration date: May 8, 2013)

Contact:
Keyvan Farahani, Ph.D.
301-451-2651; farahank@mail.nih.gov

The NCI encourages innovative translational research in the development of quantitative in vivo imaging characterization of image-guided drug delivery (IGDD) in cancer, including characterizations of the target, delivery validation, and therapy response. This initiative will support research in development of integrated imaging-based platforms for multifunctional and multiplexed drug delivery systems in cancer. Validation studies in non-human primates or large animal models and first-in-human studies directed towards translation of IGDD technology into the clinic will be considered appropriate for this initiative.